Product information

Clarinase Repetabs 120 mg - 5 mg
14
pseudo-efedrine + loratadine
0482778
9.24 / 10
Locked

Product properties

7460-12-0
R01BA52, R06AX13
Bayer
Prolonged-release tablet
BE152826
04057599000634
TD
Public
152826-04

Pharmacist Assessment

Discontinued product — remaining stock available

The commercialization of this product has been stopped (reason: Replacement by another medicinal product/pack), but remaining stock is available at wholesalers (score 9.24/10). This stock will not be replenished. Plan the switch to an alternative.

Recommended alternative

Different strength — dose adjustment required. Consult the physician.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 17 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Replacement by another medicinal product/pack

Adaptation of the treatment possible (non-vital medicinal product)
Available
Until 31/05/2026

Composition

4 ingredients

Substance Type Strength CAS
Active ingredient
5 mg
79794-75-5
Active ingredient
120 mg
7460-12-0
Excipient
156.8 mg
Excipient
173.6 mg

Additional information

View on BCPI

Availability statistics

Commercialization stopped
286 days
6
0
01/06/2026